Cardiovascular and heart failure safety profile of vildagliptin: a meta‐analysis of 17 000 patients
Year: 2015
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12548
Authors: G. McInnes, M. Evans, S. Del Prato, M. Stumvoll, A. Schweizer, V. Lukashevich, Q. Shao, W. Kothny
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: vildagliptin, cardiovascular safety, heart failure risk, major adverse cardiovascular events, type 2 diabetes, GLP-1 receptor agonists, congestive heart failure, renal dysfunction, myocardial infarction, stroke, cardiovascular mortality, heart failure hospitalization, drug safety, high-risk patients, relative risk, DPP-4 inhibitors
Open Access status: closed
OpenAlex ID: W1846464686
